JPWO2022076364A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022076364A5 JPWO2022076364A5 JP2023521107A JP2023521107A JPWO2022076364A5 JP WO2022076364 A5 JPWO2022076364 A5 JP WO2022076364A5 JP 2023521107 A JP2023521107 A JP 2023521107A JP 2023521107 A JP2023521107 A JP 2023521107A JP WO2022076364 A5 JPWO2022076364 A5 JP WO2022076364A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- ganglioside
- sample
- level
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063087427P | 2020-10-05 | 2020-10-05 | |
| US63/087,427 | 2020-10-05 | ||
| PCT/US2021/053503 WO2022076364A1 (en) | 2020-10-05 | 2021-10-05 | Compositions and methods for cancer diagnosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553247A JP2023553247A (ja) | 2023-12-21 |
| JPWO2022076364A5 true JPWO2022076364A5 (https=) | 2024-10-15 |
| JP2023553247A5 JP2023553247A5 (https=) | 2024-10-15 |
Family
ID=81126198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023521107A Pending JP2023553247A (ja) | 2020-10-05 | 2021-10-05 | がん診断のための組成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250277793A1 (https=) |
| EP (1) | EP4225365A4 (https=) |
| JP (1) | JP2023553247A (https=) |
| KR (1) | KR20230155419A (https=) |
| CN (1) | CN117120086A (https=) |
| AU (1) | AU2021357695A1 (https=) |
| CA (1) | CA3197304A1 (https=) |
| IL (1) | IL301783A (https=) |
| MX (1) | MX2023003771A (https=) |
| WO (1) | WO2022076364A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL315829A (en) * | 2022-04-04 | 2024-11-01 | Aoa Dx | Mass spectrometry methods for cancer diagnosis |
| WO2025096441A1 (en) * | 2023-10-30 | 2025-05-08 | The Board Of Trustees Of The Leland Stanford Junior University | Ganglioside gm2 as a target for cancer immunotherapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2329897A1 (en) * | 1998-04-28 | 1999-11-04 | Galenica Pharmaceuticals, Inc. | Polysaccharide-antigen conjugates |
| ES2904533T3 (es) * | 2013-12-06 | 2022-04-05 | Aoa Dx | Compuesto antigangliósido para dirigirlo contra el cáncer y generar anticuerpos |
| WO2017048823A1 (en) * | 2015-09-18 | 2017-03-23 | Mackay Memorial Hospital Of Taiwan Presbyterian Church And Mackay Memorial Social Work Foundation | Immunogenic glycopeptide compounds, pharmaceutical compositions and uses thereof |
| WO2018112669A1 (en) * | 2016-12-23 | 2018-06-28 | Realist Pharma, Inc. | Ganglioside carbohydrate structures and uses thereof |
-
2021
- 2021-10-05 WO PCT/US2021/053503 patent/WO2022076364A1/en not_active Ceased
- 2021-10-05 IL IL301783A patent/IL301783A/en unknown
- 2021-10-05 MX MX2023003771A patent/MX2023003771A/es unknown
- 2021-10-05 EP EP21878327.2A patent/EP4225365A4/en active Pending
- 2021-10-05 CA CA3197304A patent/CA3197304A1/en active Pending
- 2021-10-05 CN CN202180081628.7A patent/CN117120086A/zh active Pending
- 2021-10-05 KR KR1020237014431A patent/KR20230155419A/ko active Pending
- 2021-10-05 US US18/030,426 patent/US20250277793A1/en active Pending
- 2021-10-05 AU AU2021357695A patent/AU2021357695A1/en active Pending
- 2021-10-05 JP JP2023521107A patent/JP2023553247A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10775383B2 (en) | PD-L1 antibodies and uses thereof | |
| US8067186B2 (en) | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof | |
| JP2022514197A (ja) | 抗ｂ７－ｈ３抗体 | |
| WO2015181267A1 (en) | Anti-b7-h3 antibodies and diagnostic uses thereof | |
| JP7527589B2 (ja) | 切断型の変異型Ｃａｌｒｅｔｉｃｕｌｉｎに結合する抗体、及び骨髄増殖性腫瘍の診断、予防又は治療薬 | |
| McDaniel et al. | Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node | |
| JP6944925B2 (ja) | 組織浸潤ｎｋ細胞を検出する方法 | |
| JP2024514855A (ja) | Ｄｌｌ３に対する結合分子及びその使用 | |
| JP6940505B2 (ja) | 組成物および癌の発生リスクの評価方法 | |
| WO1996028569A1 (en) | Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same | |
| JPWO2022076364A5 (https=) | ||
| JP2022520719A (ja) | 抗ｂ７ｓ１ポリペプチドおよびその使用 | |
| JP7019609B2 (ja) | 卵巣がんおよび膵臓がんのためのバイオマーカーとしてムチン様タンパク質（ｍｌｐ）を検出するためのモノクローナル抗体、組成物および方法 | |
| JP2021511068A (ja) | Ｃｅｎｔｒｉｎ−１に対する抗体、作製方法、及びその使用 | |
| EP2776465A1 (en) | Monoclonal antibodies against serotransferrin antigens, and uses therefor | |
| AU2022255908A9 (en) | Immunohistochemistry methods and kir3dl2-specific reagents | |
| TWI869740B (zh) | 一種體外檢測ｓＴＮＦＲ２蛋白濃度的方法及其檢測試劑和檢測試劑盒 | |
| WO2025151746A1 (en) | Methods and compositions for the treatment of pou2f3-driven cancer | |
| US9539348B2 (en) | Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof | |
| JP4803943B2 (ja) | 肝細胞増殖因子活性化因子阻害因子−１に対する抗体とその用途 | |
| JP2016526684A (ja) | アウグリン免疫学的検定 | |
| BR112017022635B1 (pt) | Anticorpo anti-igf-1r, kits, e métodos para a detecção in vitro ou ex vivo da presença e/ou localização de células tumorais expressando igf-1r em um indivíduo, para a detecção in vitro ou ex vivo da percentagem de células tumorais que expressam igf-1r em um indivíduo, para a determinação in vitro ou ex vivo do nível de expressão de igf-1r em células tumorais em um indivíduo, para a determinação in vitro ou ex vivo da pontuação de igf-1r de células tumorais ou de um tumor em um indivíduo, para determinar se um transtorno oncogênico é suscetível ao tratamento com uma droga de anticorpo tendo como alvo a via de igf-1r, para a determinação in vitro ou ex vivo da eficácia de um regime terapêutico conce(...) | |
| JPWO2023081818A5 (https=) |